• Peptide Nucleic Acid Clamping and Direct Sequencing in the Detection of Oncogenic Alterations in Lung Cancer: Systematic Review and Meta-Analysis

• ¼ÛÀç¿í(Song Jae-Uk) ÀÌÁ¾ÈÄ(Lee Jong-Hoo)

• Yonsei Medical Journal  2018³â 59±Ç 2È£ 211~218

• Efficacy of Pemetrexed-based Chemotherapy in Comparison to Non-Pemetrexed-based Chemotherapy in Advanced, ALK+ Non-Small Cell Lung Cancer

• Á¶Àç¹Î(Jo Jae-Min) ±è¼¼Çö(Kim Se-Hyun) ±èÀ¯Á¤(Kim Yu-Jung) ÀÌÁÖÇö(Lee Ju-Hyun) ±è¹Ì¼Ò(Kim Mi-So) ±è¹ü¼®(Keam Bhum-Suk) ±èŹÎ(Kim Tae-MIn) ±èµ¿¿Ï(Kim Dong-Wan) Çã´ë¼®(Heo Dae-Seog) Á¤ÁøÇà(Chung Jin-Haeng) ÀüÀ±°æ(Jeon Yoon-Kyung) ÀÌÁ¾¼®(Lee Jong-Seok)

• Yonsei Medical Journal  2018³â 59±Ç 2È£ 202~210

• Outcomes of Pulmonary Resection and Mediastinal Node Dissection by Video-Assisted Thoracoscopic Surgery Following Neoadjuvant Chemoradiation Therapy for Stage IIIA N2 Non-Small Cell Lung Cancer

• Àü¿µÁ¤(Jeon Yeong-Jeong) ÃÖ¿ë¼ö(Choi Yong-Soo) ÀÌ°æÁ¾(Lee Kyung-Jong) À̼¼ÈÆ(Lee Se-Hoon) ǥȫ·Ä(Pyo Hong-Ryull) ÃÖÁØ¿µ(Choi Joon-Young)

• ´ëÇÑÈäºÎ¿Ü°úÇÐȸÁö  2018³â 51±Ç 1È£ 29~34

• Lung Cancer Screening with Low-Dose CT in Female Never Smokers: Retrospective Cohort Study with Long-term National Data Follow-up

• ±èÇý¿µ(Kim Hyae-Young) Á¤±Ô¿ø(Jung Kyu-Won) ÀÓ°Ç¿µ(Lim Kun-Young) À̼öÇö(Lee Soo-Hyun) ÀüÀç°ü(Jun Jae-Kwan) ±èÁ¤¼±(Kim Jeong-Seon) (Hwangbo Bin) ÀÌÁø¼ö(Lee Jin-Soo)

• Cancer Research and Treatment  2018³â 50±Ç 3È£ 748~756

• The Effect of Hospice Consultation on Aggressive Treatment of Lung Cancer

• À¯½ÅÇý(Yoo Shin-Hye) ±è¹ü¼®(Keam Bhum-Suk) ±è¹Ì¼Ò(Kim Mi-So) ±èŹÎ(Kim Tae-MIn) ±èµ¿¿Ï(Kim Dong-Wan) Çã´ë¼®(Heo Dae-Seog)

• Cancer Research and Treatment  2018³â 50±Ç 3È£ 720~728

• Crizotinib versus Chemotherapy in Asian Patients with ALK-Positive Advanced Non-small Cell Lung Cancer

• (Nishio Makoto) ±èµ¿¿Ï(Kim Dong-Wan) (Wu Yi-Long) (Nakagawa Kazuhiko) (Solomon Benjamin J.) (Shaw Alice T.) (Hashigaki Satoshi) (Ohki Emiko) (Usari Tiziana) (Paolini Jolanda) (Polli Anna) (Wilner Keith D.) (Mok Tony)

• Cancer Research and Treatment  2018³â 50±Ç 3È£ 691~700

• Retrospective Molecular Epidemiology Study of PD-L1 Expression in Patients with EGFR-Mutant Non-small Cell Lung Cancer

• Á¶Á¾È£(Cho Jong-Ho) (Zhou Wei) ÃÖÀ±¶ó(Choi Yoon-La) ¼±Á¾¹«(Sun Jong-Mu) ÃÖÇýÁÖ(Choi Hye-Joo) ±èÅÂÀº(Kim Tae-Eun) (Dolled-Filhart Marisa) (Emancipator Kenneth) (Rutkowski Mary Anne) ±èÁø±¹(Kim Jhin-Gook)

• Cancer Research and Treatment  2018³â 50±Ç 1È£ 95~102

• Feasibility and Safety of Single-Port Video-Assisted Thoracic Surgery for Primary Lung Cancer

• Çã¿î(Heo Woon) °­µµ±Õ(Kang Do-Kyun) ¹ÎÈ£±â(Min Ho-Ki) ÀüÈñÀç(Jun Hee-Jae) ȲÀ±È£(Hwang Youn-Ho)

• ´ëÇÑÈäºÎ¿Ü°úÇÐȸÁö  2017³â 50±Ç 3È£ 190~196

• Randomized Phase II Study of Afatinib Plus Simvastatin Versus Afatinib Alone in Previously Treated Patients with Advanced Nonadenocarcinomatous Non-small Cell Lung Cancer

• ÀÌ¿µÁÖ(Lee Young-Joo) À̱âÇü(Lee Ki-Hyeong) À̰DZ¹(Lee Geon-Kook) À̼öÇö(Lee Soo-Hyun) ÀÓ°Ç¿µ(Lim Kun-Young) ÁÖÁ¤³²(Joo Jung-Nam) °íÀ±Á¤(Go Yun-Jung) ÀÌÁø¼ö(Lee Jin-Soo) ÇÑÁö¿¬(Han Ji-Youn)

• Cancer Research and Treatment  2017³â 49±Ç 4È£ 1001~1011

• Incorporating Erlotinib or Irinotecan Plus Cisplatin into Chemoradiotherapy for Stage III Non-small Cell Lung Cancer According to EGFR Mutation Status

• ÀÌ¿µÁÖ(Lee Young-Joo) ÇÑÁö¿¬(Han Ji-Youn) ¹®¼ºÈ£(Moon Sung-Ho) ³²º´È£(Nam Byung-Ho) ÀÓ°Ç¿µ(Lim Kun-Young) À̰DZ¹(Lee Geon-Kook) ±èÈïÅÂ(Kim Heung-Tae) (Yun Tak) ¾ÈÇýÁø(An Hye-Jin) ÀÌÁø¼ö(Lee Jin-Soo)

• Cancer Research and Treatment  2017³â 49±Ç 4È£ 981~989

• Efficacy and Safety of First-Line Necitumumab Plus Gemcitabine and Cisplatin Versus Gemcitabine and Cisplatin in East Asian Patients with Stage IV Squamous Non-small Cell Lung Cancer: A Subgroup Analysis of the Phase 3, Open-Label, Randomized SQUIRE Study

• ¹Ú±ÙÄ¥(Park Keun-Chil) Á¶Àº°æ(Cho Eun-Kyung) (Bello Maximino) ¾È¸íÁÖ(Ahn Myung-Ju) (Thongprasert Sumitra) ¼ÛÀº±â(Song Eun-Kee) (Soldatenkova Victoria) (Depenbrock Henrik) (Puri Tarun) (Orlando Mauro)

• Cancer Research and Treatment  2017³â 49±Ç 4È£ 937~946

• Survey of the Patterns of Using Stereotactic Ablative Radiotherapy for Early-Stage Non-small Cell Lung Cancer in Korea

• ¼Û»óÇõ(Song Sang-Hyuk) ÀåÁöÇö(Chang Ji-Hyun) ±èÇÐÀç(Kim Hak-Jae) ±è¿¬½Ç(Kim Yeon-Sil) ±èÁøÈñ(Kim Jin-Hee) ¾È¿ëÂù(Ahn Yong-Chan) ±èÀ缺(Kim Jae-Sung) ¼Û½Ã¿­(Song Si-Yeol) ¹®¼ºÈ£(Moon Sung-Ho) Á¶¹®ÁØ(Cho Moon-June) À±¼±¹Î(Youn Seon-Min)

• Cancer Research and Treatment  2017³â 49±Ç 3È£ 688~694

• ERCC1 Expression-Based Randomized Phase II Study of Gemcitabine/Cisplatin Versus Irinotecan/Cisplatin in Patients with Advanced Non-small Cell Lung Cancer

• ÇÑÁö¿¬(Han Ji-Youn) À̰DZ¹(Lee Geon-Kook) ÀÓ°Ç¿µ(Lim Kun-Young) ÀÌ¿µÁÖ(Lee Young-Ju) ³²º´È£(Nam Byung-Ho) ÀÌÁø¼ö(Lee Jin-Soo)

• Cancer Research and Treatment  2017³â 49±Ç 3È£ 678~687

• East Asian Subgroup Analysis of a Randomized, Double-Blind, Phase 3 Study of Docetaxel and Ramucirumab Versus Docetaxel and Placebo in the Treatment of Stage IV Non-small Cell Lung Cancer Following Disease Progression after One Prior Platinum-Based Therapy (REVEL)

• ¹Ú±ÙÄ¥(Park Keun-Chil) ±èÁÖÇ×(Kim Joo-Hang) Á¶Àº°æ(Cho Eun-Kyung) °­ÁøÇü(Kang Jin-Hyoung) (Jin-Yuan Shih) (Annamaria Hayden Zimmermann) (Pablo Lee) (Alexandris Ekaterine) (Tarun Puri) (Mauro Orlando)

• Cancer Research and Treatment  2016³â 48±Ç 4È£ 1177~1186

• Tolerability and Outcomes of First-Line Pemetrexed-Cisplatin Followed by Gefitinib Maintenance Therapy Versus Gefitinib Monotherapy in Korean Patients with Advanced Nonsquamous Non-small Cell Lung Cancer: A Post Hoc Descriptive Subgroup Analysis of a Randomized, Phase 3 Trial

• °­ÁøÇü(Kang Jin-Hyoung) ¾È¸íÁÖ(Ahn Myung-Ju) ±èµ¿¿Ï(Kim Dong-Wan) Á¶Àº°æ(Cho Eun-Kyung) ±èÁÖÇ×(Kim Joo-Hang) ½Å»ó¿ø(Shin Sang-Won) (Xin Wang) ±èÁ¾¼®(Kim Jong-Seok) (Mauro Orlando) ¹Ú±ÙÄ¥(Park Keun-Chil)

• Cancer Research and Treatment  2016³â 48±Ç 2È£ 458~464

• Randomized Phase II Study of Pemetrexed Versus Gefitinib in Previously Treated Patients with Advanced Non-small Cell Lung Cancer

• ±è¿µ»ý(Kim Young-Saing) Á¶Àº°æ(Cho Eun-Kyung) ¿ìÇö¼±(Woo Hyun-Sun) È«ÁؽÄ(Hong Jun-Shik) ¾ÈÈñ°æ(Ahn Hee-Kyung) ¹ÚÀαÙ(Park In-Keun) ½É¼±Áø(Sym Sun-Jin) °æ¼±¿µ(Kyung Sun-Young) °­½Å¸í(Kang Shin-Myung) ¹ÚÁ¤¿õ(Park Jeong-Woong) Á¤¼ºÈ¯(Jeong Sung-Hwan) ¹ÚÁøÈñ(Park Jin-Ny) ÀÌÀçÈÆ(Lee Jae-Hoon) ½Åµ¿º¹(Shin Dong-Bok)

• Cancer Research and Treatment  2016³â 48±Ç 1È£ 80~87

• Pemetrexed-Erlotinib, Pemetrexed Alone, or Erlotinib Alone as Second-Line Treatment for East Asian and Non-East Asian Never-Smokers with Locally Advanced or Metastatic Nonsquamous Non-small Cell Lung Cancer: Exploratory Subgroup Analysis of a Phase II Trial

• ÀÌ´ëÈ£(Lee Dae-Ho) ÀÌÁ¤½Å(Lee Jung-Shin) (Jie Wang) (Te-Chun Hsia) (Xin Wang) ±èÁ¾¼®(Kim Jong-Seok) (Mauro Orlando)

• Cancer Research and Treatment  2015³â 47±Ç 4È£ 616~629

• Pemetrexed Continuation Maintenance in Patients with Nonsquamous Non-small Cell Lung Cancer: Review of Two East Asian Trials in Reference to PARAMOUNT

• (James Chin-Hsin Yang) ¾È¸íÁÖ(Ahn Myung-Ju) (Kazuhiko Nakagawa) (Tomohide Tamura) (Helen Barraclough) (Sotaro Enatsu) (Rebecca Cheng) (Mauro Orlando)

• Cancer Research and Treatment  2015³â 47±Ç 3È£ 424~435

• Gefitinib in Selected Patients with Pre-Treated Non-Small-Cell Lung Cancer: Results from a Phase IV, Multicenter, Non-Randomized Study(SELINE)

• ÀÌ°üÈ£(Lee Kwan-Ho) À̰迵(Lee Kye-Young) Àü¿µÁØ(Jeon Young-June) Á¤¸¸È«(Jung Maan-Hong) ¼ÕÃáÈñ(Son Choon-Hee) À̹αâ(Lee Min-Ki) ·ùÁ¤¼±(Ryu Jeong-Seon) ¾ç¼¼ÈÆ(Yang Sei-Hoon) ÀÌÀçö(Lee Jae-Cheol) ±è¿µÃ¶(Kim Young-Chul) ±è¼±¿µ(Kim Sun-Young)

• °áÇÙ¹×È£Èí±âÁúȯ  2012³â 73±Ç 6È£ 303~311

• Àú¼±·® CT¸¦ ÀÌ¿ëÇÑ Æó¾Ï°ËÁø: ´ëÇÑÈäºÎ¿µ»óÀÇÇÐȸ ÀÇ°ß Á¦¾È

• Korean Society of Thoracic Radiology Guideline for Lung Cancer Screening with Low-Dose CT

• ÀÌÇöÁÖ(Lee Hyun-Ju) ±èÁøȯ(Kim Jin-Hwan) ±èÀ±°æ(Kim Yoon-Kyung) ¹Úâ¹Î(Park Chang-Min) ÀÌÁø¾Æ(Yi Chin-A) Á¤¿¬ÁÖ(Jeong Yeon-Ju)

• ´ëÇÑ¿µ»óÀÇÇÐȸÁö  2012³â 67±Ç 5È£ 349~365

• Surgical Outcomes in Small Cell Lung Cancer

• ÁÖ¹ÎÈ£(Ju Min-Ho) ±èÇü·Ä(Kim Hyeong-Ryul) ±èÁعü(Kim Joon-Bum) ±è¿ëÈñ(Kim Yong-Hee) ±èµ¿°ü(Kim Dong-Kwan) ¹Ú¼ºÀÏ(Park Seung-Il)

• ´ëÇÑÈäºÎ¿Ü°úÇÐȸÁö  2012³â 45±Ç 1È£ 40~44

• Outcome of Limited Resection for Lung Cancer

• Á¶Á¤¼ö(Cho Jeong-Su) Àü»óÈÆ(Jheon Sang-Hoon) ¹Ú¼ºÁØ(Park Sung-Joon) ¼º¼÷ȯ(Sung Sook-Whan) ÀÌÃáÅÃ(Lee Choon-Taek)

• ´ëÇÑÈäºÎ¿Ü°úÇÐȸÁö  2011³â 44±Ç 1È£ 51~57

• ¿ÏÀü ÀýÁ¦µÈ ºñ¼Ò¼¼Æ÷Æó¾Ï º´±â IB (pT2N0) ȯÀÚ¿¡¼­ ¼ö¼ú ÈÄ UFTÀÇ È¿°ú

• Impact of Postoperative Oral Administration of UFT for Completely Resected pT2N0 Non-Small Cell Lung Cancer

• ÀÌÁø±¸(Lee Jin-Gu) Á¤°æ¿µ(Chung Kyung-Young) ¹ÚÀαÔ(Park In-kyu) ±è´ëÁØ(Kim Dae-Joon) ±è±æµ¿(Kim Kil-Dong) Á¶»óÈ£(Cho Sang-Ho)

• ´ëÇÑÈäºÎ¿Ü°úÇÐȸÁö  2007³â 40±Ç 6È£ 428~434

• ÀüÀ̼º Æó¾ÏÀÇ ¿Ü°úÀû Ä¡·á

• Surgical Treatment of Pulmonary Metastases

• °­Á¤È£(Kang Jung-Ho) ³ë¼±±Õ(Ro Sun-Kyun) ±è¿µÇÐ(Kim Young-Hak) Á¤¿ø»ó(Chung Won-Sang) ±èÇõ(Kim Hyuck) ¹Ýµ¿±Ô(Ban Dong-Gyu)

• ´ëÇÑÈäºÎ¿Ü°úÇÐȸÁö  2007³â 40±Ç 2È£ 103~108

• A Comparison of Gemcitabine in Two Doses for Stage III or IV Non-small Cell Lung Cancer: a Multi-Institutional Phase II Study

• ¹ÚÈñ¼±(Park Hee-Sun) ¾ÈÁø¿µ(An Jin-Young) ÀÌ¿¬¼±(Lee Yeun-Seun) Á¤¹Ì°æ(Joung Mi-Kyong) ÀÌÀ¯Áø(Lee Yu-Jin) Á¤¼º¼ö(Jung Sung-Soo) À±È¯Áß(Yun Hwan-Jung) ±èÁÖ¿Á(Kim Ju-Ock) ±è±Ô½Ä(Kim Kyu-Sik) ±è¿µÃ¶(Kim Young-Chul) ·ùÁ¤¼±(Ryu Jeong-Seon) ±è¼±¿µ(Kim Sun-Young)

• Journal of Lung Cancer  2007³â 6±Ç 1È£ 1~7

• Randomized, Multi-center Phase II Trial of Docetaxel Plus Cisplatin Versus Etoposide Plus Cisplatin as the First-line Therapy for Patients with Advanced Non-Small Cell Lung Cancer

• Lee NS Park HS/Won JH/Hong DS/Uh ST/Lee SJ/Kim JH/Kim SK/Ahn MJ/Choi JH/Yang SC/Lee JA/Lee KS/Yim CY/Lee YC/Kim CS/Lee MH/Jung KD/Moon HL/Lee YS

• Cancer Research and Treatment  2005³â 37±Ç 6È£ 332~338

• Induction Chemotherapy Followed by Concurrent Chemoradiotherapy in Patients with Unresectable Stage III Non- small Cell Lung Cancer

• ¹ÚÈñö(Park Hee-Chul) ±è¼ö»ê(Kim Su-San) ¹èÈƽÄ(Bae Hoon-Sik) ±èÈ¿Á¤(Kim Hyo-Jung) Àå´ë¿µ(Zang Dae-Young) ¹Ú¿µÀÌ(Park Young-Iee) ±èµ¿±Ô(Kim Dong-Gyu) Á¤±â¼®(Chung Ki-Suck) ¾ÈÁø¼®(Ahn Jin-Seok)

• Journal of Lung Cancer  2005³â 4±Ç 1È£ 27~33

• ÁøÇິ±â ¼Ò¼¼Æ÷Æó¾Ï ȯÀÚ¿¡¼­ Irinotecan, CisplatinÀÇ º¹ÇÕÈ­Çпä¹ý

• A Phase II Study of Irinotecan and Cisplatin for Patients with Extensive Disease Small Cell Lung Cancer

• °­ÇõÁÖ Àå´ë¿µ

• µ¿±¹ÀÇÇР 2004³â 11±Ç 1È£ 268~276

• Æó¾ÏÀÇ Ç×¾ÏÈ­Çпä¹ý

• Chemotherapy in Lung Cancer

• ¹Ú±ÙÄ¥

• ´ëÇÑÀÇ»çÇùȸÁö  2003³â 46±Ç 1È£ 38~45

• Paclitaxel and Cisplatin with Concurrent Radiotherapy for Stage III Non-Small Cell Lung Cancer

• ä±Ô¿µ(Chai Gyu-Young) °­±â¹®(Kang Ki-Mun) ÀÌ°æ¿ø(Lee Gyeong-Won) ÀÌ¿ø¼·(Lee Won-Seop) ÀåÁ¤¼ø(Jang Joung-Soon)

• Journal of Lung Cancer  2003³â 2±Ç 2È£ 104~109

• ±¹ÇѼºº´±â ¼Ò¼¼Æ÷Æó¾Ï ȯÀÚ¿¡¼­ Á¶±â ȤÀº Áö¿¬ ±³´ë ¹æ»ç¼±-Ç×¾ÏÁ¦Ä¡·áÀÇ ÀüÇâÀû ºñ±³¿¬±¸

• Randomized Trial of Early Versus Late Alternating Radiotherapy/ Chemotherapy in Limited-Disease Patients with Small Cell Lung Cancer

• ÀÌâ°É/Chang Geol Lee ±èÁÖÇ×/±è¼º±Ô/±è¼¼±Ô/±è±Í¾ð/¼­Ã¢¿Á/Joo Hang Kim/Sung Kyu Kim/Sei Kyu Kim/Gwi Eon Kim/Chang Ok Suh

• ´ëÇѹæ»ç¼±Á¾¾çÇÐȸÁö  2002³â 20±Ç 2È£ 116~122

• ÁøÇàµÈ ºñ¼Ò¼¼Æ÷ Æó¾Ï ȯÀÚ¿¡¼­ Concurrent Chemoradiotherapy¿Í Conventional RadiotherapyÀÇ ºñ±³

• Comparison of Concurrent Chemoradiotherapy with Conventional Radiotherapy in Advanced Non-smal Cell Lung Cancer

• ±èÈÖÁ¤/Hui Jung Kim À̵¿¼ö/¼Û¼ÒÇâ/Á¤¼ö¹Ì/±è¿µ±Õ/À±¼¼Ã¶/¹®È­½Ä/¼ÛÁ¤¼·/¹Ú¼ºÇÐ/Dong Soo Lee/So Hysng Song/Su Mi Jung/Young Kyoon Kim/Se Chul Yoon/Hwa Sik Moon/Jeong Sup Song/Sung Hak Park

• °áÇÙ¹×È£Èí±âÁúȯ  1997³â 44±Ç 3È£ 493~504

• ±ÙÄ¡Àû ÀýÁ¦¸¦ ½ÃÇàÇÑ ºñ¼Ò¼¼Æ÷Æó¾ÏÀÇ º¸Á¶Ä¡·áÀÇ È¿°ú

• Effects of Postoperative Adjuvant Therapy on Completely Resected Non-Small Cell Lung Cancer

• ÀÌ°æÈñ Çö¸í¼ö ÀÌÁ¤Ã¶

• ´ëÇѿ¿­Á¾¾çÇÐȸÁö  1997³â 2±Ç 1È£ 105~119

• Á¦ÇѺ´±â ¼Ò¼¼Æ÷Æó¾Ï¿¡¼­ ÈäºÎ ¹æ»ç¼± Ä¡·áÀÇ µµÀÔ ½Ã±â¿¡ µû¸¥ Ä¡·á È¿°úÀÇ ºñ±³ ºÐ¼®

• The effects according to the timing of thoracic radiotherapy in limited stage small cell lung cancer

• ¹Ú»ó±â ±è±ÙÈ­/Á¤¼º¼ö/½Å°æ»ó/±è¾Ö°æ/Á¶ÇØÁ¤/¼­Áö¿ø/±èÁÖ¿Á/±è¼±¿µ

• °áÇÙ¹×È£Èí±âÁúȯ  1996³â 43±Ç 6È£ 903~915

• 4±â ºñ¼Ò¼¼Æ÷Æó¾Ï ȯÀÚ¿¡¼­ º¹ÇÕÈ­Çпä¹ý±º°ú º¸Á¸ÀûÄ¡·á±ºÀÇ »ýÁ¸À² ºñ±³¿¬±¸

• Survival Difference of Combination Chemotherapy versus Supportive Care in the Patients with Stage ¥³ Non-Small Cell Lung Cancer

• ±èº´ÈÆ/Byeong Hun Kim ÀÌ°æÈñ/µµ°©¼®/ÀÌÀºÁ¤/±è¼º¸ñ/Á¤ÁøÈ«/ÀÌ°üÈ£/Çö¸í¼ö/Kyung Hee Lee/Gab Suk Doh/Eun Jung Lee/Seong Mok Kim/Jin Hong Chung/Kwan Ho Lee/Myung Soo Hyun

• °áÇÙ¹×È£Èí±âÁúȯ  1996³â 43±Ç 4È£ 536~546

• ±¹¼Ò ÁøÇàµÈ ºñ¼Ò¼¼Æ÷¼º Æó¾Ï¿¡¼­ ¿Â¿­ ¹æ»ç¼±º´¿ë Ä¡·áÀÇ È¿°ú

• Thermoradiotherapy in the Treatment of Locally Advanced Nonsmall Cell Lung Cancer

• °èö½Â(Kay Chul-Seung) ÃÖÀϺÀ(Choi Ihl-Bohng) ÀåÁö¿µ(Jang Ji-Young) ÃÖº´¿Á(Choi Byung-Ok) ±èÀξÆ(Kim In-Ah) ½Å°æ¼·(Shinn Kyung-Sub)

• ´ëÇÑÄ¡·á¹æ»ç¼±°úÇÐȸÁö  1996³â 14±Ç 2È£ 115~122

• ±¹¼Ò ÁøÇàµÈ ºñ¼Ò¼¼Æ÷ Æó¾Ï¿¡¼­ º¹ÇÕ¿ä¹ý°ú ´ÜÀÏ¿ä¹ýÀÇ ºñ±³

• Comparison of Single vs Combined Modality Treatment in Locally Advanced Non-Small Cell Lung Cancer

• ±è¾Ö°æ/Ae Kyoung Kim Á¤¼º¼ö/½Å°æ»ó/¹Ú»ó±â/Á¶ÇýÁ¤/ÀÌÁ¾Áø/¼­Áö¿ø/±èÁÖ¿Á/±è¼±¿µ/Seong Su Jeong/Kyoung Sang Shin/Sang Gee Park/Hai Jeong Jo/Jong Jin Lee/Jee Won Seo/Ju Ock Kim/Sun Young Kim

• °áÇÙ¹×È£Èí±âÁúȯ  1995³â 42±Ç 4È£ 502~512

• Àü½Å±â ¼Ò¼¼Æ÷ Æó¾Ï¿¡ ´ëÇÑ EP È­Çпä¹ý°ú EP/CAV ±³´ëÈ­Çпä¹ýÀÇ ºñ±³ ¿¬±¸

• A Randomized Comparison of EP Sequential Chemotherapy Verus EP/CAV Alternating Chemotherapy for Extensive-stage Small-cell Lung Cancer

• ¼­Ã¢ÀÎ(Suh Chang-In) ¹Ú¿µ¼®(Park Young-Suk) Á¤±â¼®(Chung Ki-Suck) Çã´ë¼®(Heo Dae-Seok) ¹æ¿µÁÖ(Bang Young-Jue) ±è³ë°æ(Kim Noe-Kyeong)

• ´ëÇѾÏÇÐȸÁö  1994³â 26±Ç 5È£ 786~792

• ³â ±Ç È£ ~